Thrombocytosis in a male patient with acute promyelocytic leukaemia during all-trans retinoic (ATRA) acid treatment

We present a rather uncommon side effect observed in a 20-year-old man with acute promyelocytic leukemia during treatment with ATRA. He developed a high platelet counts reaching up to 1655×10(9)/L on day 29 of ATRA treatment, and started to recover spontaneously on day 33 of treatment, without any c...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldapt, Mahmood B., Kassem, Nancy, Al-Okka, Randa, Ghasoub, Rula, Soliman, Dina, Abdulla, Mohammad A., Mudawi, Deena, Ibrahim, Feryal, Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179098/
https://www.ncbi.nlm.nih.gov/pubmed/29633731
http://dx.doi.org/10.23750/abm.v89i3-S.7218
Descripción
Sumario:We present a rather uncommon side effect observed in a 20-year-old man with acute promyelocytic leukemia during treatment with ATRA. He developed a high platelet counts reaching up to 1655×10(9)/L on day 29 of ATRA treatment, and started to recover spontaneously on day 33 of treatment, without any change in ATRA, or adding any cytoreduction therapy. No complications associated with thrombocytosis were observed. IL-6 seems to play an important role in the pathogenesis of the thrombocytosis induced by ATRA. However, it is unclear what are the precipitating factors for this rare phenomenon and whether it is caused by certain predisposing factors that might be related to patient’s, disease pathogenesis or other unknown factors. (www.actabiomedica.it)

Ejemplares similares